| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BEC | CTRPv2 | pan-cancer | AAC | -0.061 | 0.4 |
| mRNA | Crizotinib | gCSI | pan-cancer | AAC | 0.05 | 0.4 |
| mRNA | Nutlin-3a (-) | GDSC1000 | pan-cancer | AAC | -0.029 | 0.4 |
| mRNA | HG-6-64-1 | GDSC1000 | pan-cancer | AAC | 0.029 | 0.4 |
| mRNA | BRD-K09344309 | CTRPv2 | pan-cancer | AAC | 0.063 | 0.4 |
| mRNA | clofarabine | CTRPv2 | pan-cancer | AAC | 0.024 | 0.4 |
| mRNA | ML311 | CTRPv2 | pan-cancer | AAC | 0.027 | 0.4 |
| mRNA | BRD-K34222889 | CTRPv2 | pan-cancer | AAC | -0.026 | 0.4 |
| mRNA | JQ-1 | GDSC1000 | pan-cancer | AAC | 0.028 | 0.4 |
| mRNA | Cyclopamine | FIMM | pan-cancer | AAC | -0.13 | 0.4 |